{
    "code": "02020354",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02020354",
    "time": "2020-04-10 04:52:48",
    "許可證字號": "衛署藥輸字第020354號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "108\/03\/10",
    "發證日期": "83\/03\/10",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202035401",
    "中文品名": "可邁丁錠1毫克",
    "英文品名": "COUMADIN TABLETS 1MG",
    "適應症": "1.預防及\/或治療靜脈栓塞症及其相關疾病，以及肺栓塞。2.預防或治療因心房纖維顫動及\/或更換心臟瓣膜引起之血栓性栓塞症。",
    "劑型": "110錠劑",
    "包裝": "16-1000錠瓶裝 16-1000錠鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "WARFARIN SODIUM CRYSTALLINE",
    "限制項目": "02輸　入",
    "申請商名稱": "1404501100  臺灣必治妥施貴寶股份有限公司",
    "申請商地址": "台北市松山區健康路156號4樓、5樓",
    "主製造廠": [
        {
            "製造廠名稱": "FUS0121100  Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company",
            "製造廠廠址": "BO TIERRAS NUEVAS, ROUTE 686, KM 2.3, MANATI, PUERTO RICO 00674, U.S.A.",
            "製造廠公司地址": "BRISTOL-MYERS SQUIBB COMPANY(ROUTE 206&amp; PROVINCE LINE ROAD,PRINCETON,NEW JERSEY 08543, USA)",
            "製造廠國別": "UNITED STATES",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FUS0341000  BRISTOL-MYERS SQUIBB COMPANY",
            "製造廠廠址": "ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NEW JERSEY 08543, U.S.A.",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "許可證持有者"
        },
        {
            "製造廠名稱": "FUS0373000  BRISTOL-MYERS SQUIBB COMPANY",
            "製造廠廠址": "4601 HIGHWAY 62 EAST, MOUNT VERNON, INDIANA 47620 USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "包裝及分裝"
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2012401021",
            "成分名稱": "WARFARIN SODIUM CRYSTALLINE",
            "含量描述": "1",
            "含量": "1.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "粉紅色圓形雙凸面錠片",
        "特殊氣味": "",
        "刻痕": "有",
        "形狀": "圓凸形",
        "標記一": "COUMADIN",
        "標記二": "1"
    },
    "藥物辨識外觀圖片": [
        {
            "title": "BMST Coumadin 1mg Spec-07-104-09-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02020354&Seq=427&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "附件1 Coumadin 1274054A0 Rev Oct2011[EN-clean]-102-10-30.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02020354&Seq=030&Type=9"
        },
        {
            "title": "Coumadin carton mfg site name change 1mg-104-09-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02020354&Seq=007&Type=8"
        }
    ]
}